Growing pressure for colorectal cancer screening in France:
This article was originally published in Clinica
The French society for endoscopy of the digestive system has added its voice to calls for swifter introduction nationally of colorectal screening in France. In its view, colonoscopy screening should be offered to the over 45s who are considered at risk, and Haemoccult tests to the general population from the age of 50, followed by colonoscopy where the results are positive. Haemoccult screening is already carried out in 22 departements in France; the French government foresees the introduction of colorectal screening as part of its 2003-08 cancer plan.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.